These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37219663)

  • 1. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson's Disease.
    Yadav SK; Pandey A; Sarkar S; Yadav SS; Parmar D; Yadav S
    Mol Neurobiol; 2022 Mar; 59(3):1781-1798. PubMed ID: 35023059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
    Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
    Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
    Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
    Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease.
    Wan Z; Rasheed M; Li Y; Li Q; Wang P; Li J; Chen Z; Du J; Deng Y
    Mol Neurobiol; 2023 Oct; 60(10):5642-5654. PubMed ID: 37329382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of gut miRNAs in idiopathic Parkinson's disease.
    Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T
    Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and Dysregulation of miRNA in Patients with Parkinson's Disease.
    Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
    Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients.
    Tolosa E; Botta-Orfila T; Morató X; Calatayud C; Ferrer-Lorente R; Martí MJ; Fernández M; Gaig C; Raya Á; Consiglio A; Ezquerra M; Fernández-Santiago R
    Neurobiol Aging; 2018 Sep; 69():283-291. PubMed ID: 29935433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
    Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
    Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.
    Xu F; Zhou W; Cao J; Xu Q; Jiang D; Chen Y
    Theranostics; 2017; 7(11):2849-2862. PubMed ID: 28824720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.